Benchmark Genetics is a brand that specializes in the development and production of high-performing broodstock and sex-reversed fingerlings of their Spring Tilapia® strain. This strain has been carefully selected for its fast growth, robustness, and other key commercial traits. It also exhibits improved resistance to diseases such as Streptococcus iniae, Streptococcus agalactiae, and Francisella orientalis.

Benchmark Genetics offers three business models for their Spring Tilapia® strain. Firstly, they provide direct sales of sex-reversed fingerlings to North America, specifically the USA and Canada, with a range of sizes available. Secondly, they offer distributors the opportunity to multiply and commercialize the Spring Tilapia® strain in specific regions, either on an exclusive or non-exclusive basis.

Distributors receive the latest and improved generations of the strain on a regular basis. Lastly, Benchmark Genetics also provides broodstock agreements for interested parties. With a focus on high performance, profitability, and resilience, Spring Tilapia® from Benchmark Genetics is an excellent choice for growers looking to optimize their operations and achieve success in the tilapia industry